Spetzler David Baxley bought CAI

November 7, 2025 · Form 4 insider transaction

Spetzler David Baxley bought 400 shares of Caris Life Sciences, Inc. at $23.85 per share, a transaction worth $9.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.